Development and Validation of a Machine Learning Model to Predict Near-Term Risk of Iatrogenic Hypoglycemia in Hospitalized Patients.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
entrez:
8
1
2021
pubmed:
9
1
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Accurate clinical decision support tools are needed to identify patients at risk for iatrogenic hypoglycemia, a potentially serious adverse event, throughout hospitalization. To predict the risk of iatrogenic hypoglycemia within 24 hours after each blood glucose (BG) measurement during hospitalization using a machine learning model. This retrospective cohort study, conducted at 5 hospitals within the Johns Hopkins Health System, included 54 978 admissions of 35 147 inpatients who had at least 4 BG measurements and received at least 1 U of insulin during hospitalization between December 1, 2014, and July 31, 2018. Data from the largest hospital were split into a 70% training set and 30% test set. A stochastic gradient boosting machine learning model was developed using the training set and validated on internal and external validation. A total of 43 clinical predictors of iatrogenic hypoglycemia were extracted from the electronic medical record, including demographic characteristics, diagnoses, procedures, laboratory data, medications, orders, anthropomorphometric data, and vital signs. Iatrogenic hypoglycemia was defined as a BG measurement less than or equal to 70 mg/dL occurring within the pharmacologic duration of action of administered insulin, sulfonylurea, or meglitinide. This cohort study included 54 978 admissions (35 147 inpatients; median [interquartile range] age, 66.0 [56.0-75.0] years; 27 781 [50.5%] male; 30 429 [55.3%] White) from 5 hospitals. Of 1 612 425 index BG measurements, 50 354 (3.1%) were followed by iatrogenic hypoglycemia in the subsequent 24 hours. On internal validation, the model achieved a C statistic of 0.90 (95% CI, 0.89-0.90), a positive predictive value of 0.09 (95% CI, 0.08-0.09), a positive likelihood ratio of 4.67 (95% CI, 4.59-4.74), a negative predictive value of 1.00 (95% CI, 1.00-1.00), and a negative likelihood ratio of 0.22 (95% CI, 0.21-0.23). On external validation, the model achieved C statistics ranging from 0.86 to 0.88, positive predictive values ranging from 0.12 to 0.13, negative predictive values of 0.99, positive likelihood ratios ranging from 3.09 to 3.89, and negative likelihood ratios ranging from 0.23 to 0.25. Basal insulin dose, coefficient of variation of BG, and previous hypoglycemic episodes were the strongest predictors. These findings suggest that iatrogenic hypoglycemia can be predicted in a short-term prediction horizon after each BG measurement during hospitalization. Further studies are needed to translate this model into a real-time informatics alert and evaluate its effectiveness in reducing the incidence of inpatient iatrogenic hypoglycemia.
Identifiants
pubmed: 33416883
pii: 2774716
doi: 10.1001/jamanetworkopen.2020.30913
pmc: PMC7794667
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2030913Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK111986
Pays : United States
Références
Curr Med Res Opin. 2013 Feb;29(2):101-7
pubmed: 23198978
J Diabetes Sci Technol. 2012 Mar 01;6(2):302-9
pubmed: 22538139
Diabetes Manag (Lond). 2014 Mar;4(2):165-176
pubmed: 25197322
Diabetes Care. 2009 Jul;32(7):1153-7
pubmed: 19564471
Am J Ther. 2011 Sep;18(5):355-65
pubmed: 20224321
Endocr Pract. 2007 Mar-Apr;13(2):117-24
pubmed: 17490924
J Diabetes Complications. 2014 Jul-Aug;28(4):565-72
pubmed: 24685363
PLoS One. 2015 Mar 04;10(3):e0118432
pubmed: 25738806
Endocr Pract. 2019 Dec;25(12):1295-1303
pubmed: 31412227
BMJ Open Diabetes Res Care. 2018 Mar 02;6(1):e000499
pubmed: 29527311
J Diabetes Sci Technol. 2020 May;14(3):560-566
pubmed: 32389071
Health Aff (Millwood). 2014 Jul;33(7):1123-31
pubmed: 25006137
J Hosp Med. 2007 Jul;2(4):203-11
pubmed: 17683100
Endocr Pract. 2016 Aug;22(8):959-69
pubmed: 27042740
J Gen Intern Med. 2002 Aug;17(8):646-9
pubmed: 12213147
Diabet Med. 2017 Oct;34(10):1385-1391
pubmed: 28632918
Eur J Intern Med. 2018 Jan;47:43-48
pubmed: 28882417
Diabetes Care. 2020 Jul;43(7):1504-1511
pubmed: 32350021
Diabetes Educ. 2008 Jan-Feb;34(1):75-83
pubmed: 18267993
J Stat Softw. 2008 Nov;28(7):
pubmed: 27774042
Biomed Eng Lett. 2018 Feb 6;8(1):1-3
pubmed: 30603186
Am J Health Syst Pharm. 2018 Nov 1;75(21):1714-1728
pubmed: 30279185
Am J Med. 2011 Nov;124(11):1028-35
pubmed: 22017781
Diabetes Care. 2013 May;36(5):1107-10
pubmed: 23248192
Diabetes Care. 2001 Aug;24(8):1371-6
pubmed: 11473072
Adv Anat Pathol. 2015 Sep;22(5):303-5
pubmed: 26262512
Diabet Med. 2019 Apr;36(4):434-443
pubmed: 30653706